Address: LORENZ Archiv-Systeme GmbH
Eschborner Landstrasse 75
60489 Frankfurt/Main
Germany,South Africa
Tel: +49-69-78991-901
LORENZ Life Sciences Group is the leading innovator for e-Regulatory Affairs solutions globally. As the most focused and established solution in this field, LORENZ’ software is responsible for more electronic submissions globally than any other solution on the market.
Mission
LORENZ’ mission is to engineer the world’s most desirable e-regulatory solutions by providing an exceptional end-to-end customer experience through advanced functionality, facilitated user-interface and deployment, as well as best-in-class customer services.
Welcome to the LORENZ Eco-System.
Vision
LORENZ’ vision is to continuously reduce the transactional unit costs of complying to regulatory standards and exchanging regulated information in the life sciences space. By reducing the transactional unit costs, LORENZ believes that patients can be better served through faster access to vital therapies, thereby significantly improving the quality of life.
Background
LORENZ Life Sciences Group is a member of the LORENZ Group, which started as an independent provider of electronic system solutions in 1975. The LORENZ Group has evolved to cover a number of specialized high-tech market segments and has built bridges between conventional thinking and industry-specific innovations. The multitude of specialized segments has allowed the group to transfer technologies into other areas and thereby identify new business benefits.
The Life Sciences Group was formed in 1989 and consists of a number of companies involved exclusively in providing e-submission software solutions for regulatory affairs to both industry and agency. Since 1993 LORENZ has offered a state-of-the-art submission compilation department, in which submissions are compiled on behalf of sponsors and then sent to the authorities for review. This too adds to the immense knowledge LORENZ Life Sciences has accumulated since 1989.
As the number one supplier of submission management systems in the world, LORENZ was the first vendor to understand the benefits of a fully integrated submission management system rather than merely looking at it from a publishing perspective. LORENZ is also the first vendor in its market space to be audited to GAMP4. The first eCTDs and CTDs were submitted with LORENZ’ submission management solution in early 2002. In fact, docuBridge is the only solution used both on the industry and agency-side. docuBridge is used by a number of regulatory authorities worldwide to review eCTDs and other submission formats. This makes LORENZ the leading knowledge company in electronic compilation, electronic review and publishing in the life sciences market.
In 2008, LORENZ has become a voting member of Health Level Seven (HL7).
Apart from the e-Regulatory niche market covered by the Life Sciences Group, other areas covered by the Group include:
Logic Data Systems GmbH Time/Access Control Systems
LORENZ Office-Service GmbH General Business Services
LORENZ Orga-Systeme GmbH Knowledge Management and Workflow
LORENZ Systemhaus-Gruppe LORENZ Group
In 2010, South Africa officially joined the BRICS grouping. The Indian and Russian work environments are familiar to you, considering your significant experience in these countries. How would you compare…
Medicines for Africa’s Lenias Hwenda argues that the success of the much-talked-about African Medicines Agency hinges on a critical mass of African national regulators achieving WHO Level 3 maturity status.…
Writing in the February 2024 edition of the DIA Global Forum magazine, Verena Pfaffinger and Ilona Baraniak-Lang of PharmaLex examine how the drug shortages seen in the global south during…
Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however an estimated 39 million…
Dr Benji Pretorius, the founder of Erada Technology Alliance and a malaria survivor himself, shares his insights into why the development of a truly effective malaria vaccine will only succeed…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Nevena Miletic of Roche and the IFPMA’s Africa Regulatory Network and Ian Hudson from the Bill and Melinda Gates…
The third and final piece in Lenias Hwenda of Medicines for Africa’s series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential…
The second in a three-part series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come (read part one…
In the first of a series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come, Lenias Hwenda of…
During the COVID-19 pandemic discussions around increasing access to medicines for low and middle-income countries (LMICs) were often centred on compulsory licensing. As a result, pharma companies were up in…
As part of a special focus on drug development and clinical research in Africa in February 2023’s DIA Global Forum magazine, Lisa Ursella Collins of Innomas Clinical Research, Leslie Sam…
Roughly half of Africa’s 1.1 billion people lack regular access to even the most essential medicines and most of Sub-Saharan Africa depends on imports which make up as much as…
Speaking exclusively to PharmaBoardroom, Medicines for Africa’s Lenias Hwenda gives a comprehensive overview of the African Medicines Agency, why such a regulatory body was needed, how it differs from the…
See our Cookie Privacy Policy Here
